Cost-Effectiveness Analysis of Atezolizumab Plus Chemotherapy in the First-Line Treatment of Metastatic Non-Squamous Non-Small Cell Lung Cancer
Dong Ding, Huabin Hu, Mengting Liao, Yin Shi, Longjiang She, Linli Yao, Youwen Zhu, Shan Zeng, Jin Huang
Topics & Concepts
AtezolizumabMedicineCarboplatinOncologyLung cancerInternal medicineChemotherapyCost effectivenessCost-effectiveness analysisCancerCisplatinImmunotherapyPembrolizumabRisk analysis (engineering)Cancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsHealth Systems, Economic Evaluations, Quality of Life